Gemelli Biotech Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 26

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 6

Gemelli Biotech General Information

Description

Developer of medical devices designed to provide diagnostics for the human microbiome. The company uses blood tests to measure the levels of two antibodies known to be elevated in patients with post-infectious irritable bowel syndrome and also provides a breath test system that aids in the identification of small intestinal bacterial overgrowth, enabling physicians to get an optimised diagnosis protocol for diarrhoea-predominant and mixed-type irritable bowel syndrome.

Contact Information

Website
www.gemellibiotech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2020 Progress Court
  • Suite 100-101
  • Raleigh, NC 27608
  • United States
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • 2020 Progress Court
  • Suite 100-101
  • Raleigh, NC 27608
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gemelli Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private Completed Generating Revenue
4. Early Stage VC (Series A) 08-Jun-2022 Completed Generating Revenue
3. Early Stage VC (Series A) 07-Dec-2021 Completed Generating Revenue
2. Seed Round 27-Jun-2019 $1.85M $3.85M Completed Generating Revenue
1. Seed Round 27-Nov-2018 $2M $2M Completed Startup
To view Gemelli Biotech’s complete valuation and funding history, request access »

Gemelli Biotech Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A1
Series A2
Seed Plus 1,229,508 $0.000100 $2.44 $2.44 1x $2.44 6.73%
Seed 1,333,332 $0.000100 $1.5 $1.5 1x $1.5 7.3%
To view Gemelli Biotech’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Gemelli Biotech Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Gemelli Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021361055-A1 Microbiome-derived gaseous sample collection system and methods Inactive 16-Oct-2020
AU-2021361055-A9 Microbiome-derived gaseous sample collection system and methods Inactive 16-Oct-2020
CA-3195531-A1 Microbiome-derived gaseous sample collection system and methods Pending 16-Oct-2020
EP-4228797-A1 Microbiome-derived gaseous sample collection system and methods Inactive 16-Oct-2020
EP-4228797-A4 Microbiome-derived gaseous sample collection system and methods Inactive 16-Oct-2020 A61B5/097
To view Gemelli Biotech’s complete patent history, request access »

Gemelli Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gemelli Biotech Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Carolina Angel Network Angel Group Minority
CerraCap Venture Capital Minority
LOUD Ventures Venture Capital Minority
Blue Ox Healthcare Partners Growth/Expansion Minority
Cedars-Sinai Corporation Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Gemelli Biotech FAQs

  • When was Gemelli Biotech founded?

    Gemelli Biotech was founded in 2018.

  • Where is Gemelli Biotech headquartered?

    Gemelli Biotech is headquartered in Raleigh, NC.

  • What is the size of Gemelli Biotech?

    Gemelli Biotech has 26 total employees.

  • What industry is Gemelli Biotech in?

    Gemelli Biotech’s primary industry is Diagnostic Equipment.

  • Is Gemelli Biotech a private or public company?

    Gemelli Biotech is a Private company.

  • What is Gemelli Biotech’s current revenue?

    The current revenue for Gemelli Biotech is .

  • How much funding has Gemelli Biotech raised over time?

    Gemelli Biotech has raised $57.7M.

  • Who are Gemelli Biotech’s investors?

    Carolina Angel Network, CerraCap, LOUD Ventures, Blue Ox Healthcare Partners, and Cedars-Sinai are 5 of 6 investors who have invested in Gemelli Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process